Jerussi; Thomas P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Jerussi; Thomas P..The latest application filed is for "derivatives of (-)-venlafaxine and methods of preparing and using the same".

Company Profile

0.28.53

Jerussi; Thomas P. - Charleston SC
Jerussi; Thomas P. - Framingham MA
JERUSSI; Thomas P. - Charlestown SC
Jerussi; Thomas P - Framingham MA
Jerussi, Thomas P. - Farmingham MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Derivatives Of (-)-venlafaxine And Methods Of Preparing And Using The Same App 20150299102 - Jerussi; Thomas P. ; et al.	2015-10-22
Methods of using derivatives of (-)-venlafaxine Grant 9,072,700 - Jerussi , et al. July 7, 2	2015-07-07
Methods Of Using Derivatives Of (-)-venlafaxine App 20140121283 - JERUSSI; Thomas P. ; et al.	2014-05-01
Methods of using derivatives of (-)-venlafaxine Grant 8,642,662 - Jerussi , et al. February 4, 2	2014-02-04
Derivatives of venlafaxine and methods of preparing and using the same App 20120302794 - Jerussi; Thomas P. ; et al.	2012-11-29
Derivatives of venlafaxine and methods of preparing and using the same Grant 8,269,040 - Jerussi , et al. September 18, 2	2012-09-18
Methods Of Using Derivatives Of (-)-venlafaxine App 20120232157 - Jerussi; Thomas P. ; et al.	2012-09-13
Treatment of CNS Disorders with trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine App 20120136065 - JERUSSI; Thomas P. ; et al.	2012-05-31
Treatment of CNS Disorders With trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine App 20100292340 - JERUSSI; Thomas P. ; et al.	2010-11-18
Imidazo[1,2-A]pyridine anxiolytics Grant 7,723,324 - Fang , et al. May 25, 2	2010-05-25
Treatment of CNS Disorders With trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine App 20090292026 - Jerussi; Thomas P. ; et al.	2009-11-26
Imidazo[1,2-A] pyridine anxiolytics Grant 7,566,725 - Fang , et al. July 28, 2	2009-07-28
Compositions comprising zopiclone derivatives and methods of making and using the same Grant 7,456,173 - Jerussi , et al. November 25, 2	2008-11-25
Treatment of CNS Disorders With trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine App 20080280993 - Jerussi; Thomas P. ; et al.	2008-11-13
Dosage forms of O-desmethylvenlafaxine App 20080132578 - Jerussi; Thomas P. ; et al.	2008-06-05
Imidazo[1,2-A] Pyridine Anxiolytics App 20080096867 - Fang; Q. Kevin ; et al.	2008-04-24
Compositions comprising zopiclone derivatives and methods of making and using the same Grant 7,189,715 - Jerussi , et al. March 13, 2	2007-03-13
Compositions comprising zopiclone derivatives and methods of making and using the same App 20070049590 - Jerussi; Thomas P. ; et al.	2007-03-01
Imidazo[1,2-a] Pyridine Anxiolytics App 20070043074 - Fang; Kevin ; et al.	2007-02-22
Imidazo[1,2-a] pyridine anxiolytics Grant 7,148,353 - Fang , et al. December 12, 2	2006-12-12
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide App 20060216799 - Jerussi; Thomas P. ; et al.	2006-09-28
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide Grant 7,105,699 - Jerussi , et al. September 12, 2	2006-09-12
Methods of using derivatives of (-)-venlafaxine App 20060199861 - Jerussi; Thomas P. ; et al.	2006-09-07
Salts of (-)-O-desmethylvenlafaxine App 20060199860 - Jerussi; Thomas P. ; et al.	2006-09-07
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide Grant 7,087,785 - Jerussi , et al. August 8, 2	2006-08-08
Methods of treating or preventing erectile dysfunction Grant 7,071,234 - Jerussi , et al. July 4, 2	2006-07-04
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide App 20060128993 - Jerussi; Thomas P. ; et al.	2006-06-15
Methods of making and using N-desmethylzopiclone App 20060025418 - Jerussi; Thomas P. ; et al.	2006-02-02
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide App 20060014982 - Jerussi; Thomas P. ; et al.	2006-01-19
Compositions comprising sibutramine metabolites in combination with phosphodiesterase inhibitors Grant 6,974,837 - Jerussi , et al. December 13, 2	2005-12-13
Methods of treating and preventing a convulsive state Grant 6,946,464 - Jerussi , et al. September 20, 2	2005-09-20
O-desmethylvenlafaxine and methods of preparing and using the same App 20050197392 - Jerussi, Thomas P. ; et al.	2005-09-08
Imidazo[1,2-a] pyridine anxiolytics App 20050171144 - Fang, Kevin ; et al.	2005-08-04
Methods of treating and preventing pain, anxiety, and incontinence using derivatives of (-)-venlafaxine Grant 6,911,479 - Jerussi , et al. June 28, 2	2005-06-28
Derivatives of (-)- and (+)-venlafaxine and methods of preparing and using the same App 20040180952 - Jerussi, Thomas P. ; et al.	2004-09-16
Tramadol analogs and uses thereof Grant 6,780,891 - Senanayake , et al. August 24, 2	2004-08-24
Methods of treating and preventing cerebral function disorders using sibutramine metabolites App 20040162355 - Jerussi, Thomas P.	2004-08-19
Compositions comprising zopiclone derivatives and methods of making and using the same App 20040147521 - Jerussi, Thomas P. ; et al.	2004-07-29
Methods of treating and preventing narcolepsy using enantiomerically pure (s)-didesmethylsibutramine App 20040116534 - Jerussi, Thomas P.	2004-06-17
Derivatives of venlafaxine and methods of preparing and using the same App 20040106576 - Jerussi, Thomas P. ; et al.	2004-06-03
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetra- hydro-1-napthalenamine and its formamide App 20040092605 - Jerussi, Thomas P. ; et al.	2004-05-13
Methods of treating and preventing depression using didesmethylsibutramine App 20040092481 - Jerussi, Thomas P.	2004-05-13
Treatment of CNS disorders with trans 4-3(3,4-dichlorophenyl)-1,2,3,4-tetr- ahydro-N-methyl-1-napthalenamine App 20040087661 - Jerussi, Thomas P. ; et al.	2004-05-06
Methods of treating or preventing restless leg syndrome using sibutramine metabolites App 20040067957 - Jerussi, Thomas P. ; et al.	2004-04-08
Antiemetic compositions of optically pure (+) norcisapride App 20040044039 - McCullough, John R. ; et al.	2004-03-04
Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using R(-)-ketoprofen App 20040019111 - Jerussi, Thomas P. ; et al.	2004-01-29
Methods of treating or preventing erectile dysfunction App 20030195261 - Jerussi, Thomas P. ; et al.	2003-10-16
Compositions of optically pure (+) norcisapride Grant 6,632,827 - McCullough , et al. October 14, 2	2003-10-14
Methods for the treatment of neuropathic pain and other disorders using R(-)-ketoprofen Grant 6,620,851 - Jerussi , et al. September 16, 2	2003-09-16
Tramadol analogs and uses thereof App 20030171440 - Senanayake, Chris Hugh ; et al.	2003-09-11
Methods of making and using N-desmethylzopiclone App 20030166657 - Jerussi, Thomas P. ; et al.	2003-09-04
Methods of making N-desmethylzopiclone App 20030119841 - Jerussi, Thomas P. ; et al.	2003-06-26
Compositions comprising sibutramine metabolites in combination with phosphodiesterase inhibitors App 20030096792 - Jerussi, Thomas P. ; et al.	2003-05-22
Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites App 20030087963 - Senanayake, Chris H. ; et al.	2003-05-08
Methods of treating and preventing sexual dysfunction using (+) sibutramine in combination with phosphodiesterase inhibitors App 20030078303 - Young, James W. ; et al.	2003-04-24
Methods of treating and preventing pain, anxiety, and incontinence using derivatives of (-)-venlafaxine App 20030018083 - Jerussi, Thomas P. ; et al.	2003-01-23
Methods of treating or preventing weight gain, obesity, and related disorders App 20020188029 - Jerussi, Thomas P. ; et al.	2002-12-12
Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using R(-)-ketoprofen App 20020147238 - Jerussi, Thomas P. ; et al.	2002-10-10
Methods of treating muscle spasms using N-desmethylzopiclone App 20020143016 - Jerussi, Thomas P. ; et al.	2002-10-03
Methods of treating affective disorders using derivatives of (-)-venlafaxine Grant 6,441,048 - Jerussi , et al. August 27, 2	2002-08-27
Synthesis, methods of using, and compositions of hydroxylated cyclobutylalkylamines App 20020115727 - Senanayake, Chris H. ; et al.	2002-08-22
Methods of treating affective disorders using derivatives of (-)- venlafaxine App 20020086904 - Jerussi, Thomas P. ; et al.	2002-07-04
(S)-hydroxynefazodone antipsychotic therapy App 20020077326 - Currie, Mark G. ; et al.	2002-06-20
(R)-hydroxynefazodone antipsychotic therapy App 20020058675 - Currie, Mark G. ; et al.	2002-05-16
Bupropion metabolites and methods of their synthesis and use App 20020052340 - Jerussi, Thomas P. ; et al.	2002-05-02
Methods of making and using N-desmethylzopiclone App 20020019398 - Jerussi, Thomas P. ; et al.	2002-02-14
Bupropion metabolites and methods of use Grant 6,342,496 - Jerussi , et al. January 29, 2	2002-01-29
Derivatives of (-)-venlafaxine and methods of preparing and using the same Grant 6,342,533 - Jerussi , et al. January 29, 2	2002-01-29
Methods of using and compositions comprising sibutramine metabolites optionally in combination with other pharmacologically active compounds App 20020010198 - Jerussi, Thomas P. ; et al.	2002-01-24
Methods of using and compositions comprising (+) sibutramine optionally in combination with other pharmacologically active compounds App 20020006964 - Young, James W. ; et al.	2002-01-17
Method of using and compositions comprising (-) sibutramine optionally in combination with other pharmacologically active compounds App 20020006963 - Young, James W. ; et al.	2002-01-17
Methods of making and using N-desmethylzopiclone Grant 6,339,086 - Jerussi , et al. January 15, 2	2002-01-15
Methods of treating and preventing attention deficit disorders Grant 6,331,571 - Jerussi , et al. December 18, 2	2001-12-18
(S,R) formoterol methods and compositions Grant 6,303,145 - Jerussi , et al. October 16, 2	2001-10-16
Methods for treatment of asthma using S-oxybutynin Grant 6,294,582 - Jerussi September 25, 2	2001-09-25
Compositions of optically pure (+) norcisapride App 20010020031 - McCullough, John R. ; et al.	2001-09-06
(s,r) Formoterol Methods And Compositions App 20010007679 - JERUSSI, THOMAS P. ; et al.	2001-07-12
Derivatives of (+)-venlafaxine and methods of preparing and using the same Grant 6,197,828 - Jerussi , et al. March 6, 2	2001-03-06
Methods for treating central nervous system disorders using optically pure (+) norcisapride Grant 5,877,188 - McCullough , et al. March 2, 1	1999-03-02
Method for treating emesis and central nervous system disorders using optically pure (+) norcisapride Grant 5,739,151 - McCullough , et al. April 14, 1	1998-04-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.